Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/27/2002CN1382138A Piperidine derivatives as reuptake inhibitors
11/27/2002CN1382137A Thtrahydrothiopy 2,3-diazanaphthylaone derivatives as PDE inhibitors
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders
11/27/2002CN1382134A Benzopyranyl guanidine derivtives, process for preparation thereof and pharmaceutical compositions containing them
11/27/2002CN1382125A Bicycle vasporession agonists
11/27/2002CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/27/2002CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002CN1382121A C16 unsaturated FP-selective prostaglandins analogs
11/27/2002CN1382120A Method of producing n-(4,5-bis-(methanesulfonyl)-2-methyl-benzoyl)-guanidine, hydrochloride thereof
11/27/2002CN1382119A Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof
11/27/2002CN1382118A Biocyclic amino acids aspharmaceutical agents
11/27/2002CN1382061A Pharmaceutical compositions for oral and topical administration
11/27/2002CN1382060A Dosages for treatment with anti-ErbB2 antibodies
11/27/2002CN1382055A Remedies
11/27/2002CN1382054A Novel contraceptive medicament and method for producing the same
11/27/2002CN1382053A Novel hormonal composition and use thereof
11/27/2002CN1382052A Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
11/27/2002CN1382051A Injectable bupernorphine microparticle compositions and their use
11/27/2002CN1382050A Oral formulations for anti-tumor compounds
11/27/2002CN1382049A Method for stabilizing benzimidazole compounds
11/27/2002CN1382048A Formulation of substituted benzimidazoles
11/27/2002CN1382047A Neurotherapeutic clavulanate composition and method
11/27/2002CN1382046A Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
11/27/2002CN1382045A Inhibitor for 20-hydroxy-eicosatetraenoic acid enzyme
11/27/2002CN1382044A Use of cell factor inhibiting anti-inflammatory agent in rhinovirus infection
11/27/2002CN1382043A Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials
11/27/2002CN1382042A Treatment of emphysema using RAR selective retinoid agonists
11/27/2002CN1382041A Direct comperession polymer tablet core
11/27/2002CN1382040A Therapeutic method
11/27/2002CN1382039A Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate
11/27/2002CN1382038A New and improved formulation for paclitaxel
11/27/2002CN1382037A Oral solution containing galanthamine and sweetening agent
11/27/2002CN1382036A Solubilized pharmaceutical composition for parenteral administration
11/27/2002CN1382022A Method for treatment of chronic venous insufficiencies using extract of red vine leaves
11/27/2002CN1381512A Multi-arm fork type functional polyethylene glycol preparation method and its application in medicine
11/27/2002CN1381464A Antineoplastic compound intercedenside A
11/27/2002CN1381463A Magnesium isoglycyrrhetate and its preparing process and usage
11/27/2002CN1381459A Deacidified gingko leaf and its extract and its preparing process and application
11/27/2002CN1381456A Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
11/27/2002CN1381455A Method for synthe sizing (3aS)-5, 5-dioxo-2, 3, 3a, 4-tetrahydric-1H-pyrrolo [2,1-c] [1,2,4] benzodiazine
11/27/2002CN1381449A Aralkylone pipeazine derivative and its application
11/27/2002CN1381448A Aralkylformylalkyl piperazine derivative and its application as brain nerve protector
11/27/2002CN1381257A Chinese-medicinal antihypertensive pillow
11/27/2002CN1381255A Compoiste bear gall spray for treating rhinocleisis and its preparing process
11/27/2002CN1381237A Extract for treating cardiovascular and cerebrovascular diseases
11/27/2002CN1381236A Medicinal composition containing baicalin and caffoeoylchinic acid
11/27/2002CN1381235A Baokang capsule as natural health-care product
11/27/2002CN1381234A Application of toosendanin as inducer to make differentiation and death of tumor cells
11/27/2002CN1381233A Solid disperser of quick-releasing vitamine A acid
11/27/2002CN1381174A Two-component and three-component fungicide compound
11/27/2002CN1094977C Polysaccharides having high iduronic acid content
11/27/2002CN1094943C Urethanes and ureas that induce cytokine production
11/27/2002CN1094942C Propiophenone derivatives and process for preparing the same
11/27/2002CN1094937C Farnesyltransferase inhibiting quinazolinones
11/27/2002CN1094936C New flavnoe compounds, process for preparing them and pharmaceutical compositions containing them
11/27/2002CN1094931C Antithrombotic organic nitrates
11/27/2002CN1094930C Quinoxaline and preparation method and application thereof
11/27/2002CN1094929C Acetamide derivatives, process for producing the same, and medicinal composition containing the same
11/27/2002CN1094926C Antimer pure acetacetates, its preparation method and use
11/27/2002CN1094765C External-use burn ointment
11/27/2002CN1094760C Double-layered buccal tablet of Chinese globeflower and vitamin C and its making process
11/27/2002CN1094758C Modulation of calcium channels
11/27/2002CN1094757C Isobutyl gamma-amino-butyric acid and its derivatives for treatment of pain
11/27/2002CN1094756C Combined antipyretic analgesic drug
11/27/2002CN1094755C Controlled release agent containing reamine benzene ring alcohol or it salt
11/27/2002CN1094754C Cell renewal rate compositions
11/27/2002CN1094734C Method for preparing fatty acid ester and nutriment containing fatty acid ester
11/26/2002US6486349 Amide therapeutics and methods for treating inflammatory bowel disease
11/26/2002US6486342 Substituted chiral allosteric hemoglobin modifiers
11/26/2002US6486329 Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
11/26/2002US6486326 iso-CBI and iso-CI analogs of CC-1065 duocarmycins
11/26/2002US6486325 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
11/26/2002US6486324 Forming libraries of bactericides; immobilization; side effect reduction
11/26/2002US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents
11/26/2002US6486321 Epoxidation; quaternization
11/26/2002US6486318 Single pot process for preparing metal picolinates from alpha picoline
11/26/2002US6486315 Recrystallization processes
11/26/2002US6486305 Method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
11/26/2002US6486299 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/26/2002US6486287 Such as n,n-bis(2-trimethoxysilylpropyl)ethanolamine; for silanation of surfaces such as glass and subsequent immobilization of nucleic acids and polypeptides
11/26/2002US6486286 Use of hexahydrolupulones as antibacterial agents
11/26/2002US6486214 Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
11/26/2002US6486212 Semifluorinated alkanes and the use thereof
11/26/2002US6486211 Indole compounds
11/26/2002US6486210 Such as enantiomorphs of 4-fluorostyryl-2,3,4,5,6-pentafluorobenzylsulfone; antiproliferative/anticancer agents
11/26/2002US6486209 Use for 1,3-propanediol derivatives
11/26/2002US6486208 Sustained release, and comfortable opthalmic composition and method for ocular therapy
11/26/2002US6486207 Compositions and methods for amelioration of human female sexual dysfunction
11/26/2002US6486206 Mechanical and pharmacologic therapies to treat cardiac arrest
11/26/2002US6486205 Mixture of primary fatty acids obtained from sugar cane wax
11/26/2002US6486204 Treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug
11/26/2002US6486203 Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors
11/26/2002US6486201 Agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
11/26/2002US6486200 Prodrugs for antimicrobial amidines
11/26/2002US6486199 Spiro and dispiro 1,2,4-trioxolane antimalarials
11/26/2002US6486198 Compounds and methods for the treatment of post traumatic stress disorder
11/26/2002US6486194 Alzheimer's disease
11/26/2002US6486192 Indole compounds useful for treating bacterial infections
11/26/2002US6486190 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability